
Aurinia Pharmaceuticals Hits New 52-Week High of $16.20
2025-11-05 16:48:31Aurinia Pharmaceuticals, Inc. achieved a new 52-week high of USD 16.20, reflecting its strong performance in the pharmaceuticals sector. The company has seen significant stock growth, positive net sales, and profits, alongside a solid financial profile and high institutional ownership, reinforcing its market position.
Read full news article
Aurinia Pharmaceuticals Hits Day High with 8.66% Surge in Stock Price
2025-11-03 17:44:49Aurinia Pharmaceuticals has shown strong stock performance, gaining 8.66% on October 31, 2025, and outperforming the S&P 500 over the past year. The company reported a 12.08% increase in net sales and positive results for five consecutive quarters, reflecting robust operational strength and effective capital utilization.
Read full news articleNo announcement available
Corporate Actions
No corporate action available






